$57.93
Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Spruce Biosciences stock gains after analyst backs regulatory progress
Spruce Biosciences Announces Launch of MPS3BStudy.com
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Overview
52-week range
$7.26
$240
22% of range
Avg surprise (last 2)
-25.1%
Avg reaction (last 2)
+0.1%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-6.68 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-8.94 | $-7.32 | -22.1% | -2,694% | +1.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-14.58 | — | — | — | — | financials |
| Mon Jun 30, 2025 | Jun 2025 | $-3.50 | — | — | — | — | financials |
| Tue May 6, 2025 | Mar/2025 | $-0.32 | $-0.25 | -28.0% | — | -1.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-15.75 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-16.73 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.28 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.30 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.32 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.40 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $0 | $0 | — | $602,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-17M | $-12M | — | $-8M | $-3M | $-14M | — | $-9M |
| Net income | $-16M | $-12M | — | $-8M | $-2M | $-14M | — | $-9M |
| EPS (diluted) | $-6.68 | $-8.94 | — | $-14.58 | $-3.50 | $-23.95 | — | $-15.75 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $96M | $54M | $49M | $11M | $16M | $26M | $39M | $60M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $101M | $55M | $52M | $15M | $21M | $31M | $44M | $64M |
| Total assets | $103M | $56M | $53M | $15M | $22M | $32M | $45M | $65M |
| Long-term debt | $5M | $5M | $0 | $0 | $0 | $0 | $124,000 | $524,000 |
| Total liabilities | $19M | $22M | $11M | $10M | $9M | $16M | $16M | $13M |
| Total equity | $84M | $35M | $43M | $5M | $13M | $15M | $29M | $52M |
Implied volatility — last 90 days
No IV snapshots yet for SPRB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.